These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25599844)

  • 1. An in vitro liver model on microfluidic device for analysis of capecitabine metabolite using mass spectrometer as detector.
    Zhang J; Wu J; Li H; Chen Q; Lin JM
    Biosens Bioelectron; 2015 Jun; 68():322-328. PubMed ID: 25599844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imitation of drug metabolism in human liver and cytotoxicity assay using a microfluidic device coupled to mass spectrometric detection.
    Mao S; Gao D; Liu W; Wei H; Lin JM
    Lab Chip; 2012 Jan; 12(1):219-26. PubMed ID: 22094544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the human concentrative nucleoside transporter (hCNT1) in the cytotoxic action of 5[Prime]-deoxy-5-fluorouridine, an active intermediate metabolite of capecitabine, a novel oral anticancer drug.
    Mata JF; García-Manteiga JM; Lostao MP; Fernández-Veledo S; Guillén-Gómez E; Larrayoz IM; Lloberas J; Casado FJ; Pastor-Anglada M
    Mol Pharmacol; 2001 Jun; 59(6):1542-8. PubMed ID: 11353816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioactivation of capecitabine in human liver: involvement of the cytosolic enzyme on 5'-deoxy-5-fluorocytidine formation.
    Tabata T; Katoh M; Tokudome S; Hosakawa M; Chiba K; Nakajima M; Yokoi T
    Drug Metab Dispos; 2004 Jul; 32(7):762-7. PubMed ID: 15205393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-channel cell co-culture for drug development based on glass microfluidic chip-mass spectrometry coupled platform.
    Wu J; Jie M; Dong X; Qi H; Lin JM
    Rapid Commun Mass Spectrom; 2016 Aug; 30 Suppl 1():80-6. PubMed ID: 27539420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of metabolism-dependent drug efficacy and toxicity on a multilayer organs-on-a-chip.
    Li Z; Guo Y; Yu Y; Xu C; Xu H; Qin J
    Integr Biol (Camb); 2016 Oct; 8(10):1022-1029. PubMed ID: 27605158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of hepatic drug-metabolism for glioblastoma using liver-brain chip.
    Li Z; Li D; Guo Y; Wang Y; Su W
    Biotechnol Lett; 2021 Feb; 43(2):383-392. PubMed ID: 33145669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic and pharmacodynamic comparison of fluoropyrimidine derivatives, capecitabine and 5'-deoxy-5-fluorouridine (5'-DFUR).
    Ebi H; Sigeoka Y; Saeki T; Kawada K; Igarashi T; Usubuchi N; Ueda R; Sasaki Y; Minami H
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):205-11. PubMed ID: 15844007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing prodrug metabolism and reciprocal toxicity with an integrated and humanized multi-tissue organ-on-a-chip platform.
    Rajan SAP; Aleman J; Wan M; Pourhabibi Zarandi N; Nzou G; Murphy S; Bishop CE; Sadri-Ardekani H; Shupe T; Atala A; Hall AR; Skardal A
    Acta Biomater; 2020 Apr; 106():124-135. PubMed ID: 32068138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro evaluation of transportability and toxicity of capecitabine and its metabolites in cells derived from normal human kidney and renal cancers.
    Damaraju VL; Mowles D; Wilson M; Kuzma M; Cass CE; Sawyer MB
    Biochem Cell Biol; 2013 Dec; 91(6):419-27. PubMed ID: 24219283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microfluidic Gut-liver chip for reproducing the first pass metabolism.
    Choe A; Ha SK; Choi I; Choi N; Sung JH
    Biomed Microdevices; 2017 Mar; 19(1):4. PubMed ID: 28074384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic cell culture and metabolism detection with electrospray ionization quadrupole time-of-flight mass spectrometer.
    Gao D; Wei H; Guo GS; Lin JM
    Anal Chem; 2010 Jul; 82(13):5679-85. PubMed ID: 20540506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pharmacokinetic comparison of capecitabine and 5'-deoxy-5-fluorouridine (doxifluridine; 5'-DFUR)].
    Minami H; Ebi H
    Gan To Kagaku Ryoho; 2005 Dec; 32(13):2053-7. PubMed ID: 16352928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of capecitabine and its three nucleoside metabolites in human plasma by high performance liquid chromatography-tandem mass spectrometry.
    Deng P; Ji C; Dai X; Zhong D; Ding L; Chen X
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 989():71-9. PubMed ID: 25808944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategy for signaling molecule detection by using an integrated microfluidic device coupled with mass spectrometry to study cell-to-cell communication.
    Mao S; Zhang J; Li H; Lin JM
    Anal Chem; 2013 Jan; 85(2):868-76. PubMed ID: 23240962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The feasibility of enzyme targeted activation for amino acid/dipeptide monoester prodrugs of floxuridine; cathepsin D as a potential targeted enzyme.
    Tsume Y; Amidon GL
    Molecules; 2012 Mar; 17(4):3672-89. PubMed ID: 22450679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring cell secretions on microfluidic chips using solid-phase extraction with mass spectrometry.
    Dugan CE; Grinias JP; Parlee SD; El-Azzouny M; Evans CR; Kennedy RT
    Anal Bioanal Chem; 2017 Jan; 409(1):169-178. PubMed ID: 27761614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the Novel Capecitabine Metabolites in Capecitabine-Treated Patients with Hand-Foot Syndrome.
    Lou Y; Wang Q; Zheng J; Wang X; Jiang W; Zheng Y; Zhao Q; Qiu Y; Zeng S
    Chem Res Toxicol; 2018 Oct; 31(10):1069-1079. PubMed ID: 30230321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new, validated HPLC-MS/MS method for the simultaneous determination of the anti-cancer agent capecitabine and its metabolites: 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, 5-fluorouracil and 5-fluorodihydrouracil, in human plasma.
    Vainchtein LD; Rosing H; Schellens JH; Beijnen JH
    Biomed Chromatogr; 2010 Apr; 24(4):374-86. PubMed ID: 19650151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo monitoring of capecitabine metabolism in human liver by 19fluorine magnetic resonance spectroscopy at 1.5 and 3 Tesla field strength.
    van Laarhoven HW; Klomp DW; Kamm YJ; Punt CJ; Heerschap A
    Cancer Res; 2003 Nov; 63(22):7609-12. PubMed ID: 14633676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.